Modulators of toll-like receptors

US9127006B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9127006-B2
Application numberUS-201414321689-A
CountryUS
Kind codeB2
Filing dateJul 1, 2014
Priority dateDec 9, 2008
Publication dateSep 8, 2015
Grant dateSep 8, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are modulators of TLRs of Formula II: pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.

First claim

Opening claim text (preview).

We claim: 1. A compound having the structure: or a pharmaceutically acceptable salt thereof, wherein: L 1 is —NH— or —O—; R 1 is C 1 -C 6 alkyl, C 1 -C 6 heteroalkyl, C 3 -C 20 heterocyclylalkyl, or C 4 -C 20 carbocyclylalkyl, wherein the heteroalkyl group containing one or more heteroatoms selected from O, N and S, and wherein the heterocyclyl group containing 1 to 4 heteroatoms selected from N, O and S; each of R 4 and R 5 independently is H or C 1 -C 6 alkyl; X 1 is C 1 -C 6 alkylene, or C 1 -C 6 heteroalkylene; D is phenyl, biphenyl or pyridinyl, wherein said phenyl, biphenyl or pyridinyl is substituted with -L 2 -NR 6 R 7 ; or D is pyridinyl, piperidinyl, piperazinyl or 1,2,3,4-tetrahydroisoquinolinyl; n is 0 or 1; R 3 is selected from the group consisting of cyano, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, —CHO, or C 4 -C 20 carbocyclylalkyl; and L 2 is C 1 -C 6 alkylene or a covalent bond; each of R 6 and R 7 independently is H, or C 1 -C 6 alkyl; or R 6 and R 7 taken together with the nitrogen to which they are attached form an unsubstituted 4-6 membered heterocycle containing 0 to 2 additional heteroatoms selected from N, O and S. 2. The compound of claim 1 , wherein X 1 is —CH 2 —. 3. The compound of claim 1 , wherein D is phenyl or biphenyl. 4. The compound of claim 1 , wherein D is pyridinyl. 5. The compound of claim 1 , wherein L 2 is —CH 2 —. 6. The compound of claim 1 , wherein L 1 is —O—. 7. The compound of claim 1 , selected from the group consisting of: or a pharmaceutically acceptable salt thereof. 8. The compound of claim 1 , having the structure: or a pharmaceutically acceptable salt thereof.

Assignees

Inventors

Classifications

  • for HIV · CPC title

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • Antivirals · CPC title

  • Antineoplastic agents · CPC title

  • for RNA viruses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9127006B2 cover?
Provided are modulators of TLRs of Formula II: pharmaceutically acceptable salts thereof, compositions containing such compounds, and therapeutic methods that include the administration of such compounds.
Who is the assignee on this patent?
Gilead Sciences Inc
What technology area does this patent fall under?
Primary CPC classification C07D475/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).